+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Endometriosis"

Endometriosis - Epidemiology Forecast to 2030 - Product Thumbnail Image

Endometriosis - Epidemiology Forecast to 2030

  • Report
  • December 2021
  • 44 Pages
  • Global
From
Endometriosis Global Clinical Trials Review, H1, 2020 - Product Thumbnail Image

Endometriosis Global Clinical Trials Review, H1, 2020

  • Clinical Trials
  • May 2020
  • 308 Pages
  • Global
From
Female Infertility: Opportunity Analysis and Forecasts to 2028 - Product Thumbnail Image

Female Infertility: Opportunity Analysis and Forecasts to 2028

  • Report
  • September 2019
  • 134 Pages
  • Global
From
Female Infertility: Epidemiology Forecast to 2028 - Product Thumbnail Image

Female Infertility: Epidemiology Forecast to 2028

  • Report
  • July 2019
  • 29 Pages
  • Global
From
From
From
From
From
From
From
Loading Indicator

Endometriosis is a condition in which the tissue that normally lines the uterus grows outside of the uterus, most commonly on the ovaries, fallopian tubes, and the tissue lining the pelvis. It is a common condition among women of reproductive age, and can cause pain, heavy menstrual bleeding, and infertility. Endometriosis is often treated with hormone therapy, surgery, or a combination of both. The Endometriosis market within the context of Women's Health is a growing field, with a focus on providing treatments and therapies to improve the quality of life for those affected. Companies in this market are developing new treatments and therapies to address the symptoms of endometriosis, as well as researching new ways to diagnose and manage the condition. Some companies in the Endometriosis market include AbbVie, Bayer, Allergan, and Myovant Sciences. Show Less Read more